The Fund for Elimination of Viral Hepatitis (DBA "EndHep2030") announces a Call for Proposals for its inaugural set of grants (March 8, 2019. San Francisco, U.S.) EndHep2030 seeks partners with innovative approaches for accelerating the elimination of viral hepatitis. A complete list of eligibility requirements, selection criteria, and additional details regarding the application process are available at www.endhep2030.org/grants.
The latest news on the fight to end viral hepatitis.
For media enquiries, contact: email@example.com.
The Fund for Elimination of Viral Hepatitis (DBA "EndHep2030") has been launched at the World Hepatitis Summit (November 1-3, 2017. Sao Paulo, Brazil). Conceived as a collaborative funding platform, EndHep2030 was a direct outcome of the International Roundtable Summit of Funding for Elimination of Viral Hepatitis (June 20-21, 2016. Hong Kong, China).
In June 2016 ZeShan Foundation, in collaboration with the United States Centers for Disease Control and Prevention (US CDC) and the World Health Organization (WHO), convened a meeting designed to stimulate critical thinking and discussion around the establishment of an international funding mechanism to support the implementation of the Global Health Sector Strategy on Viral Hepatitis (“WHO Global Hepatitis Strategy”).
- WHO released a report demonstrating the role global health donors have in catalytic funding to achieve the goals of hepatitis elimination and Universal Health Coverage. Read the report here.
On World Hepatitis Day, the Government of Pakistan announced a new ambitious plan by the Prime Minister to eliminate viral hepatitis by 2030. The plan was unveiled by Dr Zafar Mirza, Special Assistant to the Prime Minister, and aims to scale up hepatitis prevention, testing and treatment services by screening up to 140 million people in Pakistan for viral hepatitis and providing free medical treatment for those infected. Approximately, 15 million people are living with hepatitis B and C in Pakistan and more than 20,000 people die annually of hepatitis-related causes.
New initiatives were also announced for injection safety, safe blood transfusion and national infection control guidelines. The Government of Pakistan has also been able to procure hepatitis C treatment at low prices. Providing treatment to all those currently diagnosed with hepatitis C could reduce healthcare costs in Pakistan within three years. It is estimated that 16 million people in Pakistan will need antivirals.
Pakistan’s President Alvi noted, “The plan is a step forward toward improving healthcare in the country and achieving the United Nations’ Sustainable Development Goals in the long run.”